Home LiteratureArticle Details
PMID: 11404481 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.

Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R

Abstract

Signal transducer and activator of transcription (STAT) proteins perform key roles in mediating signaling by cytokines and growth factors, including platelet-derived growth factor (PDGF). In addition, Src family kinases activate STAT signaling and are required for PDGF-induced mitogenesis in normal cells. One STAT family member, Stat3, has been shown to have an essential role in cell transformation by the Src oncoprotein. However, the mechanisms by which STAT-signaling pathways contribute to mitogenesis and transformation are not fully defined. We show here that disruption of Stat3 signaling by using dominant-negative Stat3beta protein in NIH 3T3 fibroblasts suppresses c-Myc expression concomitant with inhibition of v-Src-induced transformation. Ectopic expression of c-Myc is able to partially reverse this inhibition, suggesting that c-Myc is a downstream effector of Stat3 signaling in v-Src transformation. Furthermore, c-myc gene knockout fibroblasts are refractory to transformation by v-Src, consistent with a requirement for c-Myc protein in v-Src transformation. In normal NIH 3T3 cells, disruption of Stat3 signaling with dominant-negative Stat3beta protein inhibits PDGF-induced mitogenesis in a manner that is reversed by ectopic c-Myc expression. Moreover, inhibition of Src family kinases with the pharmacologic agent, SU6656, blocks Stat3 activation by PDGF. These findings, combined together, delineate the signaling pathway, PDGF --> Src --> Stat3 --> Myc, that is important in normal PDGF-induced mitogenesis and subverted in Src transformation.

MeSH Terms
3T3 Cells Animals Cell Division/drug effects,physiology Cell Line, Transformed Cell Transformation, Neoplastic/drug effects DNA-Binding Proteins/metabolism Gene Expression Regulation Genes, myc Genes, src Mice Models, Biological Platelet-Derived Growth Factor/pharmacology Proto-Oncogene Proteins c-myc/genetics,metabolism Recombinant Proteins/metabolism STAT3 Transcription Factor Signal Transduction Trans-Activators/metabolism
Chemicals
DNA-Binding Proteins Platelet-Derived Growth Factor Proto-Oncogene Proteins c-myc Recombinant Proteins STAT3 Transcription Factor Stat3 protein, mouse Trans-Activators
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Bowman T
Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Broome M A
Sinibaldi D
Wharton W
Pledger W J
Sedivy J M
Irby R
Yeatman T
Courtneidge S A
Jove R
References (51)
51 references, click to expand
  1. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.
    Immunity. 1999 Dec;11(6):709-19 PMID: 10626893
  2. Identification of CDK4 as a target of c-MYC.
    Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2229-34 PMID: 10688915
  3. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3260-5 PMID: 10737792
  4. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.
    Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32 PMID: 10760290
  5. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
    Oncogene. 2000 Apr 20;19(17):2075-85 PMID: 10815799
  6. The role of STATs in transcriptional control and their impact on cellular function.
    Oncogene. 2000 May 15;19(21):2468-73 PMID: 10851045
  7. STATs in oncogenesis.
    Oncogene. 2000 May 15;19(21):2474-88 PMID: 10851046
  8. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.
    Oncogene. 2000 Jun 1;19(24):2867-9 PMID: 10851090
  9. Regulation of both apoptosis and cell survival by the v-Src oncoprotein.
    Cell Death Differ. 2000 Aug;7(8):685-96 PMID: 10918442
  10. Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
    Biochem Pharmacol. 2000 Oct 1;60(7):885-98 PMID: 10974196
  11. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
    Mol Cell Biol. 2000 Dec;20(23):9018-27 PMID: 11074000
  12. v-Src generates a p53-independent apoptotic signal.
    Mol Cell Biol. 2000 Dec;20(24):9271-80 PMID: 11094078
  13. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Oncogene. 2000 Nov 16;19(48):5419-27 PMID: 11114718
  14. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Cancer Res. 2001 Feb 1;61(3):1178-86 PMID: 11221849
  15. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.
    Cell. 1983 Dec;35(3 Pt 2):603-10 PMID: 6606489
  16. Protein-tyrosine kinases.
    Annu Rev Biochem. 1985;54:897-930 PMID: 2992362
  17. Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity.
    Mol Cell Biol. 1988 Aug;8(8):3345-56 PMID: 2463476
  18. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.
    EMBO J. 1990 Dec;9(13):4477-84 PMID: 2176154
  19. Molecular themes in oncogenesis.
    Cell. 1991 Jan 25;64(2):235-48 PMID: 1988146
  20. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
    Cancer Res. 1999 Oct 15;59(20):5059-63 PMID: 10537273
  21. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
    Curr Opin Oncol. 1999 Nov;11(6):490-6 PMID: 10550013
  22. Function of the c-Myc oncogenic transcription factor.
    Exp Cell Res. 1999 Nov 25;253(1):63-77 PMID: 10579912
  23. Dominant negative MYC blocks transformation by ABL oncogenes.
    Cell. 1992 Sep 18;70(6):901-10 PMID: 1525828
  24. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7696-700 PMID: 8356071
  25. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation.
    Science. 1993 Sep 24;261(5129):1736-9 PMID: 8378775
  26. Differential complementation of Bcr-Abl point mutants with c-Myc.
    Science. 1994 Apr 15;264(5157):424-6 PMID: 8153630
  27. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.
    Mol Cell Biol. 1995 Feb;15(2):1102-9 PMID: 7823926
  28. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
    Science. 1995 Jul 7;269(5220):81-3 PMID: 7541555
  29. Jak-STAT signaling induced by the v-abl oncogene.
    Science. 1995 Sep 29;269(5232):1875-7 PMID: 7569929
  30. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.
    Nature. 1995 Nov 30;378(6556):509-12 PMID: 7477410
  31. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
    Mol Cell Biol. 1996 Jul;16(7):3698-706 PMID: 8668186
  32. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription.
    J Biol Chem. 1996 May 31;271(22):13221-7 PMID: 8675499
  33. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
    J Biol Chem. 1996 Jul 12;271(28):16798-806 PMID: 8663329
  34. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.
    Immunity. 1996 Nov;5(5):449-60 PMID: 8934572
  35. STATs and gene regulation.
    Science. 1997 Sep 12;277(5332):1630-5 PMID: 9287210
  36. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
    Cell Growth Differ. 1997 Oct;8(10):1039-48 PMID: 9342182
  37. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Cell Growth Differ. 1997 Dec;8(12):1267-76 PMID: 9419415
  38. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
    Mol Cell Biol. 1998 May;18(5):2545-52 PMID: 9566874
  39. Stat3 activation is required for cellular transformation by v-src.
    Mol Cell Biol. 1998 May;18(5):2553-8 PMID: 9566875
  40. How cells respond to interferons.
    Annu Rev Biochem. 1998;67:227-64 PMID: 9759489
  41. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.
    EMBO J. 1998 Nov 16;17(22):6670-7 PMID: 9822610
  42. STAT3 is required for the gp130-mediated full activation of the c-myc gene.
    J Exp Med. 1999 Jan 4;189(1):63-73 PMID: 9874564
  43. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
    Mol Cell Biol. 1999 Feb;19(2):1101-15 PMID: 9891045
  44. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation.
    Mol Cell Biol. 1999 Feb;19(2):1401-9 PMID: 9891073
  45. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Immunity. 1999 Jan;10(1):105-15 PMID: 10023775
  46. c-Src, receptor tyrosine kinases, and human cancer.
    Adv Cancer Res. 1999;76:61-119 PMID: 10218099
  47. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mol Cell Biol. 1999 Jul;19(7):4672-83 PMID: 10373516
  48. Mysterious liaisons: the relationship between c-Myc and the cell cycle.
    Oncogene. 1999 May 13;18(19):2934-41 PMID: 10378690
  49. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction.
    Cell. 1999 Jul 23;98(2):181-91 PMID: 10428030
  50. Stat3 as an oncogene.
    Cell. 1999 Aug 6;98(3):295-303 PMID: 10458605
  51. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.
    Mol Cell Biol. 1999 Nov;19(11):7519-28 PMID: 10523640
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-06-19
Epub
2001-00-12
Pages
7319-24
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC34666
Subset
IM
Grants
NCI NIH HHS · R01 CA055652 · United States
NCI NIH HHS · R01 CA067360 · United States
NCI NIH HHS · CA55652 · United States
NCI NIH HHS · CA67360 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com